Our earliest capture with readable facts. This is our first observation, not when the company introduced these things. These website claims are not independently verified.
Alto is developing a new generation of brain biomarker-based diagnostic tests and personalized treatments for use in mental health, based on a platform built from data aggregated at scale and cutting-
All facts above belong to this capture. Unlisted fields mean we have no readable observation, not that they were absent.
How it describes itself
Similar headlines are grouped together. The quote shown is from the last capture in each group, not necessarily the exact wording throughout that period.
January 2026 – November 2026 · 5 captures · latest observed messagingThe future of psychiatry is precision
We leverage the biology of individuals’ brains to develop personalized and highly effective medicines, helping patients get better faster.
25 January 2026 · The future of psychiatry is precisionarchived page
31 January 2026 · The future of psychiatry is precisionarchived page
10 July 2026 · The future of psychiatry is precisionarchived page
15 October 2026 · The future of psychiatry is precisionarchived page
4 November 2026 · The future of psychiatry is precisioncurrent websiteHistorical capture not publicly available
January 2022 – July 2024 · 4 capturesWe make medicines with the patient in mind
Precision medicine for the brain is here. We are pioneering an approach to psychiatric drug development which matches the right patient with the right Alto drug based on AI-derived brain biomarkers.